ATS Foundation Research Program Partners

The ATS is extremely grateful to our partners in research. A guiding principle of the ATS Foundation Research Program is that it will work in partnership with other medical, research, clinical, professional, corporate, patient and non-profit organizations that are focused on the diagnosis, understanding and treatment of lung disease. Our research partners, that share research priorities and funding responsibilities, are:

Alpha-1 Foundation
American Lung Association
American Lung Association of Hawaii
American Lung Association of Oregon
American Society of Transplantation
ATS Foundation Tobacco-Dependence Research Fund
ARDS Foundation*
Asthma and Allergy Foundation of America*
Boehringer Ingelheim Pharmaceuticals, Inc.
Children’s Interstitial Lung Disease Foundation*
Coalition for Pulmonary Fibrosis*
COPD Foundation*
Cystic Fibrosis Foundation*
Foundation for Sarcoidosis Research
GlaxoSmithKline
Hermansky-Pudlak Syndrome Network*
The LAM Foundation**
LAM Treatment Alliance
LUNGevity Foundation
Merck
The Nathan Cummings Foundation
Pfizer, Inc.
Pulmonary Fibrosis Foundation
Pulmonary Hypertension Association*
Respiratory Health Association of Metropolitan Chicago*
Respironics Foundation
Sarcoidosis Research Institute**
Sepsis Alliance*
Veterans Administration

* These organizations are members of the ATS Public Advisory Roundtable (for more information about ATS PAR, please click here).
** These organizations are emeritus members of ATS PAR.